Ludwig Enterprises, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OID
Ludwig Enterprises, an early-stage genomics company, is seeking to raise approximately $13.55 million through a firm commitment public offering of common units to fund clinical studies and commercialize its mRNA-based breast cancer test.
OID
Ludwig Enterprises, an early-stage genomics company, filed an S-1/A for a public offering to fund its operations and advance its non-invasive breast cancer diagnostic test, despite significant losses and going concern doubts.
OID
Ludwig Enterprises, Inc., a genomics technology company, has filed an S-1 registration statement for a firm commitment public offering to fund the development and launch of its mRNA genetic testing kits.